Thomas Dobner
Hamburg, HH 20251, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications
Acid sphingomyelinase is an age-dependent host cell factor for adenovirus entry and a pharmacological target for synergistic combination therapy with brincidofovir.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 10, 2026
Proviral functions of HMGB1 in HAdV-C5 replication compartments.
Journal: Microbiology spectrum
Published: September 08, 2025
Corrigendum to "The host cell factor DDX3 mediates sex dimorphism in the IFNα response of plasmacytoid dendritic cells upon TLR activation" [Pharmacol. Res. 216(June) (2025) 107764].
Journal: Pharmacological research
Published: August 02, 2025
Adenovirus E1B-55K regulates p53-dependent and -independent gene expression during infection.
Journal: PLoS pathogens
Published: June 27, 2025
Synergistic antiviral activity against human adenovirus through combination of itraconazole and brincidofovir.
Journal: British journal of pharmacology
Published: April 28, 2025
The host cell factor DDX3 mediates sex dimorphism in the IFNα response of plasmacytoid dendritic cells upon TLR activation.
Journal: Pharmacological research
Published: February 17, 2025
The protein composition of human adenovirus replication compartments.
Journal: mBio
Published: November 29, 2024
Adenovirus E1B-55K interferes with cellular IκB kinase complex subunit proteins.
Journal: Frontiers in immunology
Published: November 22, 2024
Cellular SUMO-specific proteases regulate HAdV-C5 E1B-55K SUMOylation and virus-induced cell transformation.
Journal: Frontiers in cellular and infection microbiology
Published: August 21, 2024
A comparative review of adenovirus A12 and C5 oncogenes.
Journal: Current opinion in virology
Published: May 14, 2024
Last Updated: 09/26/2026